$0.131
-0.008 (-5.90%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PASW Prediction & Forecast by Similar Chart Analysis
Alphio's PASW stock price prediction model matches the current Ping An Biomedical Co Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.13 (+0.24%). The 1-week path is $0.13 (+2.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ping An Biomedical Co Ltd Stock?
Ping An Biomedical Co Ltd (PASW) is not a good buy right now due to its significant price decline and weak financial indicators. The stock has a current price of $0.13, which is down 74.62% year-to-date and 89.46% over the past year. Additionally, the company's gross margin is low at 6.18% for Q4 2024, indicating challenges in profitability. The RSI is at 37.776, suggesting the stock is nearing oversold territory, but the overall trend remains negative. The main risk is the projected EPS of -0.69 for Q4 2025, indicating ongoing losses.
PASW stock price ended at $0.13 on Friday, after losing -5.90%
Ping An Biomedical Co Ltd (PASW) last closed at $0.1307, losing -5.90%. These facts feed the 1-day and 1-week PASW price prediction above.
Forecast Drivers
Ping An Biomedical Co Ltd (PASW) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PASW, ranked by similarity.
Seasonality analysis for PASW
Historically the probability of a positive August return for PASW is 0.00%. January offers the highest probability of a positive month at 5.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.